Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Thai

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Oncogene|June 15, 2020
Targeting platelets for improved outcome in KRAS-driven lung adenocarcinomaStephanie R Hyslop, Marliese Alexander, Alesha A Thai, et al.
Interface Focus|June 9, 2016
Dental abrasion as a cutting processPeter W Lucas, Mark Wagner, Khaled Al-Fadhalah, et al.
Scientific Reports|January 19, 2020
Hard plant tissues do not contribute meaningfully to dental microwear: evolutionary implicationsAdam van Casteren, David S Strait, Michael V Swain, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1983
Endemic goiter in VietnamJ M Hershman, D T Due, B Sharp, et al.
Journal of Clinical Medicine|June 19, 2024
Stereotactic Body Radiotherapy in Recurrent and Oligometastatic Head and Neck TumoursJodie L M Tham, Sweet Ping Ng, Richard Khor, et al.
Journal for Immunotherapy of Cancer|August 20, 2021
Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysisDanny Rischin, Nikhil I Khushalani, Chrysalyne D Schmults, et al.
Cancers|April 13, 2024
Optimising Patient Outcomes in Tongue Cancer: A Multidisciplinary ApproachJasper de Boer, Rebecca Barnett, Anthony Cardin, et al.
The New England Journal of Medicine|June 5, 2018
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell CarcinomaMichael R Migden, Danny Rischin, Chrysalyne D Schmults, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2019
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registryJ Mazieres, A Drilon, A Lusque, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Oncogene|June 15, 2020
Targeting platelets for improved outcome in KRAS-driven lung adenocarcinomaStephanie R Hyslop, Marliese Alexander, Alesha A Thai, et al.
Interface Focus|June 9, 2016
Dental abrasion as a cutting processPeter W Lucas, Mark Wagner, Khaled Al-Fadhalah, et al.
Scientific Reports|January 19, 2020
Hard plant tissues do not contribute meaningfully to dental microwear: evolutionary implicationsAdam van Casteren, David S Strait, Michael V Swain, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1983
Endemic goiter in VietnamJ M Hershman, D T Due, B Sharp, et al.
Journal of Clinical Medicine|June 19, 2024
Stereotactic Body Radiotherapy in Recurrent and Oligometastatic Head and Neck TumoursJodie L M Tham, Sweet Ping Ng, Richard Khor, et al.
Journal for Immunotherapy of Cancer|August 20, 2021
Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysisDanny Rischin, Nikhil I Khushalani, Chrysalyne D Schmults, et al.
Cancers|April 13, 2024
Optimising Patient Outcomes in Tongue Cancer: A Multidisciplinary ApproachJasper de Boer, Rebecca Barnett, Anthony Cardin, et al.
The New England Journal of Medicine|June 5, 2018
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell CarcinomaMichael R Migden, Danny Rischin, Chrysalyne D Schmults, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2019
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registryJ Mazieres, A Drilon, A Lusque, et al.
Pageof 5